Higlance Laboratories Private Limited

Higlance Laboratories Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U24239DL2003PTC120847 Incorporated 11 June 2003 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma
Revenue · FY 2025
₹75.98 Cr
▲ 7% YoY
Net profit · FY 2025
₹6.26 Cr
Net margin 8.2%
EBITDA · FY 2025
₹11.94 Cr
EBITDA margin 15.7%
Authorised capital
₹6 Cr
Registered with MCA
Paid-up capital
₹6 Cr
Issued & subscribed
Open charges
₹1.86 Cr
Secured borrowings
Company age
23 yrs
Est. 2003
Employees · EPFO
406
Provident fund records

About Higlance Laboratories Private Limited

Data last updated:

Higlance Laboratories Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 June 2003 and has been in existence for over 23 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2003PTC120847. Its GSTIN is 07AABCH2836H1ZQ (Delhi). The company holds 3 GST registrations, all of them active.

The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹6 Cr. It is led by directors including Sanjay Kumar Singh (Managing Director) and Ajay Singh (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1204 Hemkunt Chambers 89 Nehru Place, New Delhi, Delhi, India – 110019.

As per the financials filed for FY 2025, the company reported a revenue of ₹75.98 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹6.26 Cr (net margin 8.2%) and EBITDA of ₹11.94 Cr (EBITDA margin 15.7%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 11% over five years.

The company has about 406 employees on its provident fund (EPFO) records.

The company is associated with 2 brands: HiGlance Laboratories and HiGlance. As per MCA filings, the company has open charges of ₹1.86 Cr on record. Court records list 4 cases involving the company, including 4 filed against it; 1 case is pending. The company has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹7.99 Cr; the latest was in September 2011. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Vapi Care Pharma Private Limited with revenue of ₹76.81 Cr. The company has 4 MSME Form 1 returns on record between 2019 and 2024, listing 31 overdue payments to 6 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website higlance.com.

Company details

CIN U24239DL2003PTC120847
Registration Number 120847
Incorporation Date 11 June 2003
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Higlance Laboratories Private Limited's registered office is in New Delhi, Delhi. Its website is higlance.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    1204 Hemkunt Chambers 89 Nehru Place, New Delhi, Delhi, India – 110019
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Higlance Laboratories Private Limited, buy the company report.

Comprehensive company report
Higlance Laboratories Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Higlance Laboratories operates two associated brands: HiGlance Laboratories and HiGlance. Each brand links to its own profile.

BrandDescriptionWebsite
Manufactures pharmaceutical, vitamins, and nutrient products for health-conscious consumers and markets.higlance.com
Pharmaceutical production and export of medicines for various health issues from India.higlance.ru

Business activity

The main business activity of Higlance Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Higlance Laboratories Private Limited, buy the company report.

Financials of Higlance Laboratories Private Limited

FY 2024 filings available

Higlance Laboratories Private Limited reported revenue of ₹75.98 Cr (up 7% YoY) for FY 2025.

Revenue · FY 2025
₹75.98 Cr ▲ 7%
Net profit · FY 2025
₹6.26 Cr margin 8.2%
EBITDA · FY 2025
₹11.94 Cr margin 15.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 8%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 16%
5 years · compounded
▲ 10%

Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 7% growth in the latest year. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹11.94 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹6.26 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin15.7%
Net Profit Margin8.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Higlance Laboratories Private Limited, buy the company report.

Board of directors of Higlance Laboratories Private Limited

Higlance Laboratories has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Kalawati DeviDirector11 Jun 200323 Years 5 MonthsCurrent
Ajay SinghWhole-Time Director11 Jun 200323 Years 5 MonthsCurrent
Sanjay Kumar SinghManaging Director11 Jun 200323 Years 5 MonthsCurrent

Peer comparison

Higlance Laboratories Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Vapi Care Pharma Private Limited₹76.81 Cr (FY 2025)-11.0%Vapi, Valsad, Gujarat, India
Eskag Pharma Pvt Ltd₹76.72 Cr (FY 2024)0.0%Kolkata, West Bengal, India
Mercury Laboratories Limited₹76.17 Cr (FY 2025)-1.0%Mumbai, Maharashtra, India
Vovantis Laboratories Private Limited₹76.05 Cr (FY 2025)67.0%Vadodara, Gujarat, India
Higlance Laboratories Private Limitedthis company₹75.98 Cr (FY 2025)₹6.26 Cr8.2%7.0%406New Delhi, Delhi, India
Vital Therapeutics and Formulations Private Limited₹75.96 Cr (FY 2024)2.0%Hyderabad, Telangana, India
Bennet Pharmaceuticals Limited₹75.82 Cr (FY 2025)11.0%Vadodara, Gujarat, India
Mccoy Pharma Private Limited₹75.62 Cr (FY 2024)-30.0%Boisar, Maharashtra, India

To see the full peer comparison of Higlance Laboratories Private Limited, buy the company report.

Auditor

Higlance Laboratories Private Limited is audited by Naveen Jain & Co. for the financial year 2024.

Auditor firmFinancial yearFirm registration number
Naveen Jain & Co.FY 2024010358N

Shareholding

The shareholding of Higlance Laboratories Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Higlance Laboratories Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.86 Cr
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹1.86 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
19 Oct 200610028203State Bank of India₹1.86 CrOpen

To see the full charge records of Higlance Laboratories Private Limited, buy the company report.

Total charge records: 1 View all charges

Deals & funding

Higlance Laboratories Private Limited has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹7.99 Cr; the latest was in September 2011.

Total deals
3
Funding rounds
2
Secondary share transfer
1
Disclosed funding
₹7.99 Cr

Deals on record (3 of 3)

WhenDealAmountParties
Sep 2011Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2011Funding round₹3 CrInvestors: an individual
Nov 2006Funding round₹4.99 CrInvestors: an individual

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Higlance Laboratories Private Limited has 4 MSME Form 1 returns on record between 2019 and 2024, listing 31 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 6)

SupplierAmount dueDue sinceReported on
Kambert Machinery Company Private Limited
Om Distributors
Premier Drug House
Electrolab (India) Private Limited
S K Pharma Machinery Private Limited

To see the full MSME payment records of Higlance Laboratories Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Higlance Laboratories Private Limited has a workforce of 406 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
406
Active EPFO establishments
1
Employee growth
-5.1%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27406
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Higlance Laboratories Private Limited, buy the company report.

GST

Higlance Laboratories has 3 GST registrations: 3 active.

Total GSTINs
3
Active
3
GSTINStateStatusRegistered on
07AABCH2836H1ZQDelhiActive01 Jul 2017
09AABCH2836H1ZMUttar PradeshActive01 Jul 2017
10AABCH2836H1Z3BiharActive01 Jul 2017

To see the full GST registrations and return filing status of Higlance Laboratories Private Limited, buy the company report.

Recent activity

Higlance Laboratories Private Limited has 7 board changes on record since 2003: 3 appointments and 4 cessations. The latest: Anishrava Agrawal ceased to be Company Secretary on 31 May 2024.

AGM
Higlance Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Anishrava Agrawal ceased to be Company Secretary.
Filing
Higlance Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with State Bank Of India of Rs. 1.86 Cr registered on 19 Oct 2006 with Charge ID 10028203 was modified on 10 Mar 2021.
Ceased
Ajay Singh ceased to be Director.
Ceased
Sanjay Kumar Singh ceased to be Director.
Ceased
Dinesh Gupta ceased to be Company Secretary.
Charges
A charge with State Bank Of India amounted to Rs. 1.86 Cr with Charge ID 10028203 was registered on 19 Oct 2006.
Appointed
Ajay Singh was appointed as Whole-Time Director.
Appointed
Kalawati Devi was appointed as Director.
Appointed
Sanjay Kumar Singh was appointed as Managing Director.
Incorporation
11 Jun 2003
Higlance Laboratories Private Limited was registered on 11 Jun 2003 with Roc Delhi & aged 23 years 5 months as per MCA records.

Frequently asked questions

Higlance Laboratories is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 June 2003 (23+ years old) and is registered under CIN U24239DL2003PTC120847.

Higlance Laboratories has 3 current directors:

The latest financial statements of Higlance Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Higlance Laboratories is 07AABCH2836H1ZQ, registered in Delhi. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 09AABCH2836H1ZM (Uttar Pradesh), 10AABCH2836H1Z3 (Bihar).

The CIN (Corporate Identification Number) of Higlance Laboratories is U24239DL2003PTC120847. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Higlance Laboratories has 4 court cases on record: 4 filed against it. 1 is pending.

Higlance Laboratories was incorporated on 11 June 2003, making it 23+ years old. It is registered with the Registrar of Companies, Delhi.

Higlance Laboratories has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹7.99 Cr; the latest was in September 2011.

The peers of Higlance Laboratories by revenue are Vapi Care Pharma Private Limited, Eskag Pharma Pvt Ltd, Mercury Laboratories Limited, Vovantis Laboratories Private Limited, Vital Therapeutics and Formulations Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Anishrava Agrawal ceased to be Company Secretary on 31 May 2024. Ajay Singh ceased to be Director on 10 Mar 2018. Sanjay Kumar Singh ceased to be Director on 10 Mar 2018. Higlance Laboratories has 7 board changes on record in total.

Higlance Laboratories has 4 MSME Form 1 returns on record between 2019 and 2024, listing 31 overdue payments to 6 micro and small suppliers. The latest return was filed on 01 May 2024.

Higlance Laboratories can be reached through the website higlance.com. Its registered office is in New Delhi, Delhi, India.